Matthias W Riepe Selected Research

Matthias W Riepe Research Topics

Disease

16	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 10/2005
7	Dementia (Dementias) 01/2018 - 01/2006
4	Cognitive Dysfunction 01/2018 - 01/2005
4	Hypoxia (Hypoxemia) 06/2008 - 01/2002
3	Stroke (Strokes) 01/2008 - 02/2004
2	Depressive Disorder (Melancholia) 01/2020 - 07/2015
2	Body Weight (Weight, Body) 12/2007 - 03/2005
1	Hypertension (High Blood Pressure) 01/2018
1	Essential Tremor (Essential Tremors) 07/2015
1	Neurobehavioral Manifestations 03/2013
1	Inflammation (Inflammations) 12/2011
1	Prodromal Symptoms 12/2011
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2009
1	Disease Progression 01/2007
1	Ischemia 03/2003
1	Brain Ischemia (Cerebral Ischemia) 03/2003

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 07/2015 - 01/2007
3	Amyloid (Amyloid Fibrils)IBA 01/2018 - 06/2008
3	Rivastigmine (Exelon)FDA LinkGeneric 03/2014 - 01/2006
3	Cholinergic Agents (Cholinergics)IBA 03/2014 - 01/2007
3	tau Proteins (tau Protein)IBA 11/2011 - 06/2009
3	3-nitropropionic acidIBA 06/2008 - 03/2003
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	LithiumIBA 07/2015 - 06/2009
2	Amyloid beta-PeptidesIBA 01/2012 - 11/2011
2	LipidsIBA 12/2011 - 01/2008
2	Excitatory Amino Acid Transporter 2IBA 06/2008 - 03/2003
2	Ticlopidine (Ticlid)FDA LinkGeneric 01/2008 - 03/2005
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2008 - 03/2005
2	Clopidogrel (Plavix)FDA Link 01/2008 - 03/2005
2	Memantine (Namenda)FDA Link 01/2007 - 01/2006
2	NAD (NADH)IBA 03/2005 - 02/2004
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2018
1	nilvadipine (Escor)IBA 01/2018
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 07/2015
1	Glucose (Dextrose)FDA LinkGeneric 07/2015
1	Primidone (Sertan)FDA LinkGeneric 07/2015
1	Citalopram FDA LinkGeneric 01/2012
1	Bupropion (Wellbutrin)FDA LinkGeneric 01/2012
1	Antidepressive Agents (Antidepressants)IBA 01/2012
1	Apolipoproteins E (ApoE)IBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 12/2011
1	Glycogen Synthase Kinase 3IBA 06/2009
1	Glycogen Synthase (Synthase I)IBA 06/2009
1	Therapeutic UsesIBA 06/2009
1	Phosphotransferases (Kinase)IBA 06/2009
1	amyloid beta-protein (1-42)IBA 06/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2008
1	Antihypertensive Agents (Antihypertensives)IBA 01/2008
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2008
1	Donepezil (Aricept)FDA LinkGeneric 08/2007
1	EsterasesIBA 10/2005
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2005
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 03/2005
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 03/2005
1	RNA (Ribonucleic Acid)IBA 03/2003
1	Glutamic Acid (Glutamate)FDA Link 03/2003
1	Excitatory Amino AcidsIBA 03/2003
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 03/2003
1	ZincIBA 01/2002

Therapy/Procedure

4	Therapeutics 03/2014 - 02/2004
3	Activities of Daily Living (ADL) 03/2013 - 06/2010
2	Aftercare (After-Treatment) 01/2013 - 12/2007
1	Polypharmacy 07/2015
1	Self-Help Devices (Assistive Technology) 01/2014
1	Institutionalization (Institutionalized Persons) 01/2014
1	Complementary Therapies (Alternative Medicine) 12/2013
1	Nursing Care 03/2013
1	Secondary Prevention 01/2008
1	Injections 12/2007
1	Ambulatory Care (Outpatient Care) 01/2005